Early treatment of multiple sclerosis with Rebif (recombinant human interferon beta): design of the study.

Multiple sclerosis (Houndmills, Basingstoke, England)

Volumn 1 Suppl 1, Issue , 1995, Pages

  Comi, G ^a   Barkhof, F ^a   Durelli, L ^a   Edan, G ^a   Fernandez, O ^a   Filippi, M ^a   Hartung, H P ^a   Hommes, O R ^a   Seeldrayers, P ^a   Soelberg Sorensen, P ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; IMMUNOLOGICAL ADJUVANT; RECOMBINANT PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; HUMAN; METHODOLOGY; MULTICENTER STUDY; MULTIPLE SCLEROSIS; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ADULT; CLINICAL TRIALS, PHASE III; DOUBLE-BLIND METHOD; HUMANS; INTERFERON-BETA; MULTICENTER STUDIES; MULTIPLE SCLEROSIS; RANDOMIZED CONTROLLED TRIALS; RECOMBINANT PROTEINS; RESEARCH DESIGN;

EID: 0029420091     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)